Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients (ISAV)

NCT01578213 is registered in ClinicalTrials.gov with University of Milano Bicocca as lead sponsor.

NCT NCT01578213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01578213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients (ISAV)
Lead sponsor
University of Milano Bicocca
Phase
Phase 4
Overall status
Completed
Start date
November 9, 2011
Completion date
November 28, 2018
Enrollment
112 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia